Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marisa P McGinley

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2024
Improving Access to MS Care Through TechnologyMarisa P McGinley
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2024
The landscape of multiple sclerosis registries: Strengths and limitationsMarisa P McGinley, Ali Manouchehrinia
Neurologic Clinics|November 23, 2020
Advances in the Treatment of Multiple SclerosisCarolyn Goldschmidt, Marisa P McGinley
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2022
The value of patient-reported outcome measures for multiple sclerosisMarisa P McGinley, Brittany Lapin
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbiditiesAlise Carlson, Marisa P McGinley
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2024
Multiple sclerosis can be diagnosed solely with dissemination in space: CommentaryMarisa P McGinley, Jeffrey A Cohen
Lancet (London, England)|June 27, 2021
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditionsMarisa P McGinley, Jeffrey A Cohen
Expert Opinion on Drug Safety|November 2, 2016
Safety of monoclonal antibodies for the treatment of multiple sclerosisMarisa P McGinley, Brandon P Moss, Jeffrey A Cohen
JAMA|February 23, 2021
Diagnosis and Treatment of Multiple Sclerosis: A ReviewMarisa P McGinley, Carolyn H Goldschmidt, Alexander D Rae-Grant
Neurology|January 2, 2024
Geographic Disparities in Access to Neurologists and Multiple Sclerosis Care in the United StatesMarisa P McGinley, Tucker Harvey, Rocio Lopez, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2024
Improving Access to MS Care Through TechnologyMarisa P McGinley
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2024
The landscape of multiple sclerosis registries: Strengths and limitationsMarisa P McGinley, Ali Manouchehrinia
Neurologic Clinics|November 23, 2020
Advances in the Treatment of Multiple SclerosisCarolyn Goldschmidt, Marisa P McGinley
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2022
The value of patient-reported outcome measures for multiple sclerosisMarisa P McGinley, Brittany Lapin
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbiditiesAlise Carlson, Marisa P McGinley
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2024
Multiple sclerosis can be diagnosed solely with dissemination in space: CommentaryMarisa P McGinley, Jeffrey A Cohen
Lancet (London, England)|June 27, 2021
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditionsMarisa P McGinley, Jeffrey A Cohen
Expert Opinion on Drug Safety|November 2, 2016
Safety of monoclonal antibodies for the treatment of multiple sclerosisMarisa P McGinley, Brandon P Moss, Jeffrey A Cohen
JAMA|February 23, 2021
Diagnosis and Treatment of Multiple Sclerosis: A ReviewMarisa P McGinley, Carolyn H Goldschmidt, Alexander D Rae-Grant
Neurology|January 2, 2024
Geographic Disparities in Access to Neurologists and Multiple Sclerosis Care in the United StatesMarisa P McGinley, Tucker Harvey, Rocio Lopez, et al.
Pageof 3